Vaspin in atherosclerotic disease and cardiovascular risk in axial spondyloarthritis: a genetic and serological study
-
Published:2021-04-13
Issue:1
Volume:23
Page:
-
ISSN:1478-6362
-
Container-title:Arthritis Research & Therapy
-
language:en
-
Short-container-title:Arthritis Res Ther
Author:
Rueda-Gotor Javier, López-Mejías Raquel, Remuzgo-Martínez Sara, Pulito-Cueto Verónica, Corrales Alfonso, Lera-Gómez Leticia, Portilla Virginia, González-Mazón Íñigo, Blanco Ricardo, Expósito Rosa, Mata Cristina, Llorca Javier, Hernández-Hernández Vanesa, Rodríguez-Lozano Carlos, Barbarroja Nuria, Castro Rafaela Ortega, Vicente Esther, Fernández-Carballido Cristina, Martínez-Vidal María Paz, Castro-Corredor David, Anino-Fernández Joaquín, Peiteado Diana, Plasencia-Rodríguez Chamaida, Galíndez-Agirregoikoa Eva, García-Vivar María Luz, Gualillo Oreste, Quevedo-Abeledo Juan Carlos, Castañeda Santos, Ferraz-Amaro Iván, González-Gay Miguel Á., Genre FernandaORCID
Abstract
Abstract
Background
Vaspin is a novel anti-inflammatory adipokine associated with cardiovascular (CV) disease and inflammation in chronic inflammatory conditions different from axial spondyloarthritis (axSpA). Given the high incidence of CV disease (mainly due to accelerated atherosclerosis) exhibited by axSpA patients, we wondered if vaspin could also be a key molecule in this process. However, data on the role of vaspin regarding atherosclerotic disease in the context of axSpA is scarce. For this reason, we aimed to evaluate the implication of vaspin, at the genetic and serological level, in subclinical atherosclerosis and CV risk in axSpA.
Methods
This study included 510 patients diagnosed with axSpA. Carotid ultrasound (US) was performed to evaluate the presence of subclinical atherosclerosis. Three vaspin gene variants (rs2236242, rs7159023, and rs35262691) were genotyped by TaqMan probes. Serum vaspin levels were assessed by enzyme-linked immunosorbent assay. Statistical analysis was performed using STATA® v.11.1.
Results
Serum vaspin levels were significantly higher in female patients than in males and also in obese patients when compared to those with normal weight (p < 0.05). At the genetic level, we disclosed that the minor allele of rs2236242 (A) was associated with lower serum vaspin levels in axSpA, while the rs7159023 minor allele (A) was linked to higher serum levels (p < 0.05). When the three polymorphisms assessed were combined conforming haplotypes, we disclosed that the TGC haplotype related to high serum levels of vaspin (p = 0.01). However, no statistically significant association was observed between vaspin and markers of subclinical atherosclerosis, both at the genetic and serological level.
Conclusions
Our results revealed that vaspin is linked to CV risk factors that may influence on the atherosclerotic process in axSpA. Additionally, we disclosed that serum vaspin concentration is genetically modulated in a large cohort of patients with axSpA.
Funder
IDIVAL Instituto de Salud Carlos III Xunta de Galicia, Consellería de Educación, Universidade e Formación Profesional and Consellería de Economía, Emprego e Industria
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Raine C, Keat A. Axial spondyloarthritis. Medicine. 2018;46(4):231–6. https://doi.org/10.1016/j.mpmed.2018.01.005. 2. Papagoras C, Voulgari PV, Drosos AA. Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis. Clin Exp Rheumatol. 2013;31(4):612–20. 3. Moltó A, Nikiphorou E. Comorbidities in spondyloarthritis. Front Med (Lausanne). 2018;5:62. 4. Genre F, Rueda-Gotor J, Remuzgo-Martínez S, Pulito-Cueto V, Corrales A, Mijares V, Lera-Gómez L, Portilla V, Expósito R, Mata C, Blanco R, Llorca J, Hernández-Hernández V, Vicente E, Fernández-Carballido C, Martínez-Vidal MP, Castro-Corredor D, Anino-Fernández J, Rodríguez-Lozano C, Gualillo O, Quevedo-Abeledo JC, Castañeda S, Ferraz-Amaro I, López-Mejías R, González-Gay MÁ. Omentin: a biomarker of cardiovascular risk in individuals with axial spondyloarthritis. Sci Rep. 2020;10(1):9636. https://doi.org/10.1038/s41598-020-66816-x. 5. Genre F, López-Mejías R, Miranda-Filloy JA, Ubilla B, Carnero-López B, Blanco R, et al. Adipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitis. Biomed Res Int. 2014;2014:860651.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|